Commit Biologics is a biotechnology company focused on leveraging the activation of the complement system to develop innovative treatments for cancer and autoimmune diseases. The company is advancing its proprietary BiCE platform to identify and develop drug candidates, aiming to transform therapeutic approaches in these challenging medical areas.
Leadership & Board
Current Number of Employees29
Current LinkedIn Followers3,051
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$6M
Total Amount Raised$6M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$6M
Latest Funding Amount$6M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Commit Biologics had 29 employees as of April 27, 2026. The number of employees increased by 1 (3.57%) week-over-week.
29Latest Employee Count
1(3.57%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Commit Biologics had 3,051 followers as of April 27, 2026. The number of followers increased by 47 (1.56%) week-over-week.
3,051Latest Followers Count
47(1.56%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.